Physician profile
Christopher M Hogan
NPI 1881759744
$2,525.12
in general payments reported to CMS, 2019-2025
18 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $187 · 2021: $278 · 2022: $455 · 2023: $549 · 2024: $275 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $690.01 | 2019-2025 | Total30, Hydrus Microstent, Voyager Dslt |
| Johnson & Johnson Vision Care, INC. | $330.28 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $283.72 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $260.28 | 2019-2021 | |
| Visioneering Technologies, INC. | $146.09 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $143.08 | 2019-2025 | |
| Oyster Point Pharma, INC. | $102.12 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $97.07 | 2021-2023 | |
| Abbvie INC. | $93.60 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $83.52 | 2023 | Syfovre |
| Notal Vision, INC. | $72.02 | 2021 | |
| Coopervision INC. | $68.84 | 2019-2024 | Myday Contact Lens |
| Janssen Pharmaceuticals, INC | $37.94 | 2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $33.98 | 2025 | Xdemvy |
| Allergan, INC. | $32.15 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Derma Sciences, INC. | $21.82 | 2019 | |
| Kala Pharmaceuticals, INC. | $15.26 | 2021 | |
| Shire North American Group INC | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.